Skip to main content
Livermore
Livermore
ZHEN

Amundi

SEC CIK
0001330387
Latest filing
Aug 26, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
1,929,853
Value
$65.4M
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of TEVA by Amundi, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,929,853$65.4M<0.1%+164,167+9.3%AddedHolders
Q1 20261,765,686$53.2M<0.1%−1,463,440−45.3%ReducedHolders
Q4 20253,229,126$100.8M<0.1%+2,011,914+165.3%AddedHolders
Q3 20251,217,212$24.3M<0.1%−106,211−8.0%ReducedHolders
Q2 20251,323,423$22.6M<0.1%+644,665+95.0%AddedHolders
Q1 2025678,758$10.1M<0.1%+105,846+18.5%AddedHolders
Q4 2024572,912$12.3M<0.1%−80,958−12.4%ReducedHolders
Q3 2024653,870$11.5M<0.1%−701−0.1%ReducedHolders
Q2 2024654,571$11.0M<0.1%+114,100+21.1%AddedHolders
Q1 2024540,471$6.91M<0.1%+105,578+24.3%AddedHolders
Q4 2023434,893$4.96M<0.1%−80,710−15.7%ReducedHolders
Q3 2023515,603$4.47M<0.1%+6,280+1.2%AddedHolders
Q2 2023509,323$3.81M<0.1%+58,430+13.0%AddedHolders
Q1 2023450,893$4.15M<0.1%+40,547+9.9%AddedHolders
Q4 2022410,346$4.58M<0.1%+17,550+4.5%AddedHolders
Q3 2022392,796$3.47M<0.1%+84,282+27.3%AddedHolders
Q2 2022308,514$2.13M<0.1%+1,093+0.4%AddedHolders
Q1 2022307,421$3.13M<0.1%+52,730+20.7%AddedHolders
Q4 2021254,691$2.34M<0.1%+5,664+2.3%AddedHolders
Q3 2021249,027$2.43M<0.1%−9,155−3.5%ReducedHolders
Q2 2021258,182$2.56M<0.1%–No prior filingHolders